Orio Therapeutics

Orio Therapeutics is a biotechnology company dedicated to creating the next generation of regenerative medicines by leveraging protein engineering and targeted drug delivery technologies. The company's innovative platform addresses the fundamental limitations of current treatments, with the potential to enhance efficacy and reduce side effects across various therapeutic areas. Orio Therapeutics is headquartered at the BioArk technology hub in Monthey, Valais, Switzerland, with a second headquarters located at Monash University in Melbourne, Australia.